申联生物涨2.07%，成交额7634.50万元，主力资金净流出748.00万元

Company Overview - Shenlian Bio is located in Minhang District, Shanghai, established on June 28, 2001, and listed on October 28, 2019. The company specializes in the research, production, and sales of veterinary biological products, with 99.24% of its main business revenue coming from this sector [1][2]. Financial Performance - As of June 30, Shenlian Bio reported a revenue of 122 million yuan for the first half of 2025, a year-on-year decrease of 3.68%. The net profit attributable to the parent company was -12.87 million yuan, showing a year-on-year increase of 62.71% [2]. - The company has cumulatively distributed 158 million yuan in dividends since its A-share listing, with 47.22 million yuan distributed over the past three years [3]. Stock Performance - On September 12, Shenlian Bio's stock price increased by 2.07%, reaching 11.85 yuan per share, with a trading volume of 76.35 million yuan and a turnover rate of 1.61%. The total market capitalization is 4.866 billion yuan [1]. - Year-to-date, the stock price has risen by 116.64%, with a 0.77% increase over the last five trading days, a 10.85% increase over the last 20 days, and a 106.45% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on August 19, where it recorded a net purchase of 16.15 million yuan [1]. Shareholder Information - As of June 30, the number of shareholders for Shenlian Bio was 9,466, an increase of 6.46% from the previous period. The average circulating shares per person decreased by 6.06% to 43,380 shares [2]. Industry Classification - Shenlian Bio belongs to the agricultural, forestry, animal husbandry, and fishery sector, specifically in the animal health industry, and is associated with concepts such as small-cap stocks, pet economy, margin trading, vaccines, and biomedicine [2].